- Conditions
- Knee Osteoarthritis
- Interventions
- TPX-100 50mg, TPX-100 100mg, TPX-100 200mg, TPX-100 20mg, Placebo
- Drug
- Lead sponsor
- OrthoTrophix, Inc
- Industry
- Eligibility
- 25 Years to 75 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Seattle, Washington
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Mild to Moderate Knee OA
- Interventions
- Previous treated with TPX-100
- Other
- Lead sponsor
- OrthoTrophix, Inc
- Industry
- Eligibility
- 25 Years to 75 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Covina, California
- Conditions
- Osteoarthritis (OA) of the Knee
- Interventions
- TPX-100 200mg, Once weekly for 4 weeks, PBS
- Drug · Other
- Lead sponsor
- OrthoTrophix, Inc
- Industry
- Eligibility
- 50 Years to 80 Years
- Enrollment
- 270 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 33
- States / cities
- Scottsdale, Arizona • Tucson, Arizona • Carrolton, California + 26 more